captured official filings
Odyssey Health, Inc.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filings
captured official filings
What to review next
Rules are applied to retained SEC filing types in this issuer record. They prioritize reading work; they are not ratings or conclusions.
- CRITICALEFFECT2025-12-30 · form-type review cueSEC source →
- CRITICAL424B32025-12-30 · form-type review cueSEC source →
- WATCHS-12025-12-19 · form-type review cueSEC source →
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
Public registration text delta
Comparing S-1 filed 2025-12-19 with S-1/A filed 2025-08-15.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- shares42 → 15-27
- risk factor9 → 0-9
- offering13 → 20+7
- proceeds6 → 0-6
- control1 → 4+3
- dilution2 → 0-2
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
- S-1 true exhibit label correction 0001626644 0001626644 2025-08-15 2025-08-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares As filed with the Securities and Exchange Commission on August 15, 2025.
- In September and October 2022 and March 2023, in connection with entering into consulting agreements, we issued consultants 2,300,000 shares of our common stock valued at an average price of $0.19 per share for a total value of $433,800.
- As consideration, the consultant was granted a five-year stock option for 50,000 shares of common stock at $0.17 per share with a value of $7,700.
- Odyssey Health Incorporated S-1 false 0001626644 0001626644 2025-12-19 2025-12-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares As filed with the Securities and Exchange Commission on December 19, 2025 .
- PROSPECTUS 18,000,000 Shares Common Stock This prospectus relates to the resale of up to Eighteen Million (18,000,000) shares of our common stock by Mast Hill Fund, L.P. (“Mast Hill Fund”) upon the conversion of promissory notes and warrants being registered under this Form S-1.
- The shares of our Common Stock to which this prospectus relates may be issued by us to Mast Hill Fund pursuant to a Maintenance Agreement and Securities Purchase Agreement (the “Purchase Agreement”) entered into with Mast Hill Fund, dated November 13, 2025.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
What to verify next
Generated from retained official filing types and chronology. This is a work sequence, not legal, accounting, compliance, investment or transaction advice.
- Registration & offering path (8 retained)
Read the latest registration filing, then monitor for an amendment, EFFECT notice or 424B prospectus. - Current disclosure path (31 retained)
Open the retained current reports and identify the reported item, effective date and later update. - Financial & ownership record (43 retained)
Review periodic financial, ownership and governance records in their original filing context.
A dated Download Edition preserves this source-linked view for a project file.
Know what the paid record contains.
This is a dated working copy of the public issuer record, organized for a project file—not a separate data feed or an opinion.
Best when you need to preserve what was visible, attach it to a project, or hand a source-linked record to a colleague, counsel or internal reviewer.
Turn this issuer page into a project-file deliverable.
US$29 one time. For the moment you need to preserve the official record, hand it to a colleague or attach it to a deal file. No subscription, account or recurring charge. Download begins in this browser after payment is verified.
- Source-linked filing chronology and registration path
- Filing-change radar plus financing, legal, tax/lien and regulatory disclosure cues
- Official-source index for project-file archiving and downloadable CSV export
Pay once · verified PayPal checkout · immediate HTML and CSV delivery.
Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
Specific public-record cues, separated from generic language
Reads selected SEC filing text by sentence. Contents-page labels, generic risk language and allocation discussion are excluded; historical financing language is kept separate.
- FINANCING
and Subsidiaries Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) Common Stock Additional Paid-In Accumulated Total Stockholders’ Shares Dollars Capital Deficit Deficit Balances, July 31, 2025 96,709,763 $ 96,710 $ 55,694,429 $ ( 62,745,837 ) $ ( 6,954,698 ) Common stock issued for conversion of accrued interest and fees 1,144,000 1,144 81,224 – 82,368 Common stock issued for conversion of outstanding principal 2,000,000 2,000 142,000 – 144,000 Warrants issue
10-Q · 2026-06-12 · official SEC source ↗ - FINANCING
common stock – 432,053 Financing costs paid with issuance of common stock 5,250 – Gain on extinguishment of accounts payable ( 85,369 ) – Changes in operating assets and liabilities: (Increase) in prepaid expenses and other current assets ( 45,334 ) ( 32,234 ) Increase (decrease) in accounts payable and accrued wages ( 45,452 ) 189,973 Increase in accounts payable and accrued wages, officers ( 3,826 ) 279,966 Increase in accrued interest 309,300 147,336 Net cash used in operating activities ( 886,
10-Q · 2026-06-12 · official SEC source ↗
Scope: automated text screening of selected SEC filings only. Each cue requires review of the linked filing; it does not confirm a claim, legal status, tax status, financing completion or current issuer condition.
Financing, legal and disclosure cues
This screen counts source documents with a reading cue, never the number of underlying events. A cue may be generic risk language; open the cited SEC source before drawing any conclusion.
View screened SEC sources (4)
Coverage boundary: this is a keyword screen of selected SEC filings only. It is not a court-docket search, tax-compliance review, lien clearance, sanctions screen, adverse-media search or a complete count of financings. A zero result means no matching term in the readable documents screened—not that the underlying issue is absent. Verify each cue in the linked official filing and use the appropriate independent professionals.
Official filing path for financing review
Registration, amendment, prospectus, shelf and current-report nodes are organized here as a reading path. Use the SEC source for terms, status and materiality.
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- S-1Initial registration statementOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 424B3Prospectus / offering documentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- S-1/ARegistration amendmentOpen SEC source →
- S-1/ARegistration amendmentOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- S-1Initial registration statementOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
- 8-KCurrent report — review financing contextOpen SEC source →
Interpretation boundary: filing counts are not financing-round counts, proceeds, closing status or current capitalization. A registration, prospectus or report can relate to different purposes; use the linked official filing and appropriate advisers to verify each event.
What the latest offering documents say
Candidate sentence excerpts from readable official SEC filing text. This provides a fast reading layer for offering structure and terms; it is not a normalized term sheet or a transaction conclusion.
Offering structure
Candidate language describing the securities or registration structure.
“Page SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS ii PROSPECTUS SUMMARY 1 THE OFFERING 2 RISK FACTORS 3 USE OF PROCEEDS 5 MARKET FOR COMMON STOCK AND DIVIDEND POLICY 5 MANAGEMENT 6 THE MAST HILL FUND TRANSACTION 12 SELLING STOCKHOLDERS 15 PLAN OF DISTRIBUTION 16 DESCRIPTION OF CAPITAL STOCK 18 LEGAL MATTERS 20 EXPERTS 20 WHERE YOU CAN FIND MORE INFORMATION 21 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURI”424B3 · 2025-12-30 · Open SEC source →
Shares / price
Candidate language about shares, units or offering-price terms.
“Mast Hill Fund may sell the shares of common stock described in this prospectus in a number of different ways and at varying prices.”424B3 · 2025-12-30 · Open SEC source →
Use of proceeds
Candidate language describing stated proceeds or intended use.
“Page SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS ii PROSPECTUS SUMMARY 1 THE OFFERING 2 RISK FACTORS 3 USE OF PROCEEDS 5 MARKET FOR COMMON STOCK AND DIVIDEND POLICY 5 MANAGEMENT 6 THE MAST HILL FUND TRANSACTION 12 SELLING STOCKHOLDERS 15 PLAN OF DISTRIBUTION 16 DESCRIPTION OF CAPITAL STOCK 18 LEGAL MATTERS 20 EXPERTS 20 WHERE YOU CAN FIND MORE INFORMATION 21 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURI”424B3 · 2025-12-30 · Open SEC source →
Convertible / warrant terms
Candidate language about conversion, warrants or related instruments.
“In addition, on November 13, 2025, we entered into a Purchase Agreement with Mast Hill Fund and issued a promissory note with a maximum principal amount of up to $25,000,000 to be drawn in multiple tranches of up to $500,000.”424B3 · 2025-12-30 · Open SEC source →
View offering documents screened (5)
Extraction boundary: wording can be incomplete, duplicated, conditional or superseded by later filings. The system does not calculate proceeds, share counts, dilution or closing status from these excerpts. Verify every term in the linked official SEC filing.
Captured filing chronology
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- S-1Registration & offeringOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- 424B3Registration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- S-1Registration & offeringOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- SC 13G/AOwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- SC 13DOwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 4OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.